1. Targeting iron-mediated retinal degeneration by local delivery of transferrin
- Author
-
Jean-Claude Jeanny, Francine Behar-Cohen, Christophe Klein, Laurent Jonet, Marie-Christine Naud, Antonin Oudar, Marianne Berdugo, Stéphane Galiacy, Quentin Le Rouzic, Charlotte Andrieu-Soler, Mohamed El Sanharawi, Hélène Coppin, Yves Courtois, François Malecaze, Marie-Paule Roth, Emilie Picard, Chloé Latour, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Physiopathologie de Toulouse-Purpan (INSERM U563 - CNRS UMR1037), Centre National de la Recherche Scientifique (CNRS)-Centre de lutte contre le cancer (CLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Institut Claudius Regaud, Hôpital Ophtalmique Jules-Gonin [Lausanne], Université de Lausanne (UNIL)-Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Picard, Emilie, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut Claudius Regaud-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre de lutte contre le cancer (CLCC)-Centre National de la Recherche Scientifique (CNRS), and Université de Lausanne = University of Lausanne (UNIL)-Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV)
- Subjects
Male ,RNA, Messenger/genetics ,MESH: Inflammation ,Retinal degeneration ,Pathology ,Animals ,Cells, Cultured ,Disease Models, Animal ,Homeostasis/drug effects ,Immunoenzyme Techniques ,Inflammation/chemically induced ,Inflammation/prevention & control ,Iron/toxicity ,Mice ,Oxidative Stress/drug effects ,Rats ,Rats, Wistar ,Real-Time Polymerase Chain Reaction ,Retinal Degeneration/chemically induced ,Retinal Degeneration/metabolism ,Reverse Transcriptase Polymerase Chain Reaction ,Transferrin/pharmacology ,[SDV]Life Sciences [q-bio] ,medicine.disease_cause ,Biochemistry ,chemistry.chemical_compound ,0302 clinical medicine ,MESH: Reverse Transcriptase Polymerase Chain Reaction ,Homeostasis ,MESH: Animals ,chemistry.chemical_classification ,MESH: Iron ,0303 health sciences ,MESH: Oxidative Stress ,MESH: Real-Time Polymerase Chain Reaction ,Retinal Degeneration ,Neurodegenerative diseases ,Transferrin ,Neuroprotection ,Cell biology ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,MESH: Homeostasis ,MESH: Transferrin ,MESH: Cells, Cultured ,medicine.medical_specialty ,MESH: Rats ,MESH: Retinal Degeneration ,Iron ,Biology ,Transferrin Corresponding Author: Dr Emilie Picard ,03 medical and health sciences ,Physiology (medical) ,medicine ,RNA, Messenger ,MESH: Immunoenzyme Techniques ,MESH: Mice ,Hemochromatosis ,MESH: RNA, Messenger ,030304 developmental biology ,Inflammation ,Retina ,Retinal pigment epithelium ,PhD Corresponding Author's Institution: INSERM ,Retinal ,MESH: Rats, Wistar ,medicine.disease ,MESH: Male ,Retinal Degeneration/prevention & control ,chemistry ,Oxidative stress ,030221 ophthalmology & optometry ,sense organs ,MESH: Disease Models, Animal - Abstract
International audience; Iron is essential for retinal function but contributes to oxidative stress-mediated degeneration. Iron retinal homeostasis is highly regulated and transferrin (Tf), a potent iron chelator, is endogenously secreted by retinal cells. In this study, therapeutic potential of a local Tf delivery was evaluated in animal models of retinal degeneration. After intravitreal injection, Tf spread rapidly within the retina and accumulated in photoreceptors and retinal pigment epithelium, before reaching the blood circulation. Tf injected in the vitreous prior and, to a lesser extent, after light-induced retinal degeneration, efficiently protected the retina histology and function. We found an association between Tf treatment and the modulation of iron homeostasis resulting in a decrease of iron content and oxidative stress marker. The immunomodulation function of Tf could be seen through a reduction in macrophage/microglial activation as well as modulated inflammation responses. In a mouse model of hemochromatosis, Tf had the capacity to clear abnormal iron accumulation from retinas. And in the slow P23H rat model of retinal degeneration, a sustained release of Tf in the vitreous via non-viral gene therapy efficently slowed-down the photoreceptors death and preserved their function. These results clearly demonstrate the synergistic neuroprotective roles of Tf against retinal degeneration and allow identify Tf as an innovative and not toxic therapy for retinal diseases associated with oxidative stress.
- Published
- 2015
- Full Text
- View/download PDF